73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr
A promising discovery in the fight against incurable cancers

A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal

A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal
Researchers gain new insights into chromosome shortening and identify new potential cancer drug targets

Researchers gain new insights into chromosome shortening and identify new potential cancer drug targets

by Institute of Cancer ResearchALT-reliant cells, with telomeres being marked by the green dots. Credit: Cancer and Genome Stability Team at the ICRA new study has provided insights into an impor

Researchers gain new insights into chromosome shortening and identify new potential cancer drug targets

by Institute of Cancer ResearchALT-reliant cells, with telomeres being marked by the green dots. Credit: Cancer and Genome Stability Team at the ICRA new study has provided insights into an impor
Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show
Study finds new, unexpected mechanism of cancer cell spread

Study finds new, unexpected mechanism of cancer cell spread

by Keck School of Medicine of USCResearchers from the Keck School of Medicine of USC used imaging techniques to study how the protein GRP78 controls cancer cell behavior. In the top row, human lu

Study finds new, unexpected mechanism of cancer cell spread

by Keck School of Medicine of USCResearchers from the Keck School of Medicine of USC used imaging techniques to study how the protein GRP78 controls cancer cell behavior. In the top row, human lu
Researchers renew obsolete concept by using folate for cancer drug delivery

Researchers renew obsolete concept by using folate for cancer drug delivery

by Raymond A. Macdougall,National Institutes of HealthImages of cancer tumor cells taken with a confocal laser scanning microscope. The top row of images show that the anti-cancer formulation de

Researchers renew obsolete concept by using folate for cancer drug delivery

by Raymond A. Macdougall,National Institutes of HealthImages of cancer tumor cells taken with a confocal laser scanning microscope. The top row of images show that the anti-cancer formulation de
Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainCombining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better tha

Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainCombining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better tha
'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

by Johns Hopkins University School of MedicineNew method called ARTEMIS uses machine learning to shed light on human genome "dark matter" involved in cancer and other diseases. Credit:

'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

by Johns Hopkins University School of MedicineNew method called ARTEMIS uses machine learning to shed light on human genome "dark matter" involved in cancer and other diseases. Credit:
New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus
Colorectal cancer: Tipping the scales

Colorectal cancer: Tipping the scales

by Ludwig Maximilian University of MunichMicrograph of an organoids, which were generated from intestinal epithelial cells cultered ex vivo. Ap4-deficient organoids formed less protrusions/crypts

Colorectal cancer: Tipping the scales

by Ludwig Maximilian University of MunichMicrograph of an organoids, which were generated from intestinal epithelial cells cultered ex vivo. Ap4-deficient organoids formed less protrusions/crypts
Cancer of the appendix: Very rare, but genes may play role

Cancer of the appendix: Very rare, but genes may play role

by Cara MurezWhile appendix cancer is rare, for a small percentage of patients the disease may be linked to a particular genetic variant, a new study suggests.Researchers built on earlier research wit

Cancer of the appendix: Very rare, but genes may play role

by Cara MurezWhile appendix cancer is rare, for a small percentage of patients the disease may be linked to a particular genetic variant, a new study suggests.Researchers built on earlier research wit
Fighting cancer on Earth and in space using high-energy protons

Fighting cancer on Earth and in space using high-energy protons

byUS Department of EnergyLeft: production rate as a function of proton energy of parent radioisotopes selenium-72 (Se-72) (1) & germanium-68 (Ge-68) (2). Right, a Positron Emission Tomograph

Fighting cancer on Earth and in space using high-energy protons

byUS Department of EnergyLeft: production rate as a function of proton energy of parent radioisotopes selenium-72 (Se-72) (1) & germanium-68 (Ge-68) (2). Right, a Positron Emission Tomograph